XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.540
+0.120 (4.96%)
At close: Jun 18, 2026, 4:00 PM EDT
2.578
+0.038 (1.50%)
After-hours: Jun 18, 2026, 7:22 PM EDT
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
5.75M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | 1 | 20.00% | 3 | 3 |
| Dec 31, 2014 | 5 | - | - | 3 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| BioAtla | 41 |
| Aptevo Therapeutics | 33 |
| AIM ImmunoTech | 21 |
| Cardio Diagnostics Holdings | 17 |
| Soligenix | 14 |
| Genprex | 13 |
| Processa Pharmaceuticals | 12 |
XTLB News
- 4 weeks ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Compliance Challenges Amid Stock Surge - GuruFocus
- 4 weeks ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq - GlobeNewsWire
- 7 weeks ago - 3 Penny Stocks to Watch Now, 4/30/26 - TipRanks
- 7 weeks ago - XTL Biopharmaceuticals (XTLB) to Acquire Psyga Bio, Shares Surge 58.7% - GuruFocus
- 7 weeks ago - XTL Biopharmaceuticals to acquire Psyga Bio - TheFly
- 7 weeks ago - XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies - GlobeNewsWire
- 3 months ago - XTL Biopharmaceuticals trading halted, news pending - TheFly
- 3 months ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus